L01EA02 dasatinib
ATC group of level 5 – chemical substance · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 55 medicines in this group.
- 36 prescription only (POM)
- 19 no longer supplied or not available
Active substance: Dasatinib – all medicines with this substance, also in combinations.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,815 medicines
- L01 Antineoplastic agents 1,028 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 354 medicines
- L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01EA02 dasatinib 55 medicines
- L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 354 medicines
- L01 Antineoplastic agents 1,028 medicines
Medicines
Other groups of the same level
- L01EA01 imatinib 22 medicines
- L01EA03 nilotinib 8 medicines
- L01EA04 bosutinib 11 medicines
- L01EA05 ponatinib 5 medicines
Other names of the ATC group
- German: L01EA02 Dasatinib
- German: L01EA02 Dasatinib
- Italian: L01EA02 Dasatinib
- Turkish: L01EA02 dasatinib
- Czech: L01EA02 Dasatinib
- Slovak: L01EA02 Dazatinib
- Spanish: L01EA02 Dasatinib
- German (Switzerland): L01EA02 Dasatinib
- French (Switzerland): L01EA02 Dasatinib
- Italian (Switzerland): L01EA02 Dasatinib
- Dutch: L01EA02 Dasatinib
- English (Canada): L01EA02 Dasatinib
- French (Canada): L01EA02 Dasatinib
- French: L01EA02 dasatinib
- Polish: L01EA02 Dazatynib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EA02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
